AAM
LJPC

Advisors Asset Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Advisors Asset Management’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-13,698
Closed -$425K – 1659
2018
Q1 		$425K Sell
13,698
-986
-7% -$31.8K 0.01% 1085
2017
Q4 		$473K Sell
14,684
-435
-3% -$14.2K 0.01% 1090
2017
Q3 		$526K Sell
15,119
-17,940
-54% -$577K 0.01% 1048
2017
Q2 		$984K Sell
33,059
-3,339
-9% -$95.7K 0.02% 887
2017
Q1 		$1.09M Sell
36,398
-3,839
-10% -$98K 0.02% 839
2016
Q4 		$705K Sell
40,237
-3,448
-8% -$66.1K 0.01% 993
2016
Q3 		$1.04M Sell
43,685
-2,791
-6% -$52.6K 0.02% 851
2016
Q2 		$744K Buy
46,476
+3,465
+8% +$62.2K 0.01% 964
2016
Q1 		$899K Buy
43,011
+19,609
+84% +$350K 0.02% 899
2015
Q4 		$632K Buy
23,402
+9,711
+71% +$265K 0.01% 1054
2015
Q3 		$380K Buy
+13,691
New +$431K 0.01% 1178

Other funds holding LJPC

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Advisors Asset Management's LJPC Position: Q2 2018 in Review

Advisors Asset Management sold out of La Jolla Pharmaceutical Company (LJPC) in Q2 2018, closing a stake of 13,698 shares — an estimated $425K sold.

Advisors Asset Management first reported a position in LJPC in Q3 2015 and held it in 11 quarters. The position peaked at $1.09M in Q1 2017. 95 funds tracked by Wall St. Rank hold LJPC as of Q2 2018.

  • Advisors Asset Management reported no remaining La Jolla Pharmaceutical Company position as of Q2 2018 after selling out during the quarter.
  • Advisors Asset Management sold 13,698 La Jolla Pharmaceutical Company shares in Q2 2018, an estimated $425K.
  • Advisors Asset Management first reported a position in La Jolla Pharmaceutical Company in Q3 2015 and held it in 11 quarters.
  • Advisors Asset Management's La Jolla Pharmaceutical Company position peaked at $1.09M in Q1 2017.
  • 95 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q2 2018.

Based on Advisors Asset Management's 13F filing for Q2 2018, filed 15 Aug 2018.